ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 25

$555K Total Retail Price of All Prescriptions

Rank: 5 out of 25

243 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 4,113 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 35%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 150 116 1 1
LEVOTHYROXINE SODIUM 149 127 2 5
LISINOPRIL 134 100 3 7
METOPROLOL TARTRATE 127 89 4 8
AMLODIPINE BESYLATE 125 114 5 2
PANTOPRAZOLE SODIUM 106 72 6 43
HYDROCODONE-ACETAMINOPHEN 100 72 S3 7 40
FUROSEMIDE 96 76 8 3
SPIRIVA 88 83 9 66
METFORMIN HCL 83 62 10 10
TAMSULOSIN HCL 78 72 11 17
CARVEDILOL 76 61 12 16
ATORVASTATIN CALCIUM 72 66 13 4
LEVOFLOXACIN 68 49 14 92
DIOVAN HCT 67 59 15 20
NEXIUM 65 40 16 15
OMEPRAZOLE 65 34 16 6
CLOPIDOGREL 64 57 18 19
ADVAIR DISKUS 64 50 18 27
LANTUS SOLOSTAR 63 53 20 96
ZOLPIDEM TARTRATE 63 46 20 13
METOPROLOL SUCCINATE 59 56 22 9
OXYCODONE HCL-ACETAMINOPHEN 58 27 S2 23 99
JANUVIA 57 42 24 35
CYMBALTA 57 29 24 59
HYDROCHLOROTHIAZIDE 56 36 26 18
PLAVIX 50 48 27 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 35 27 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.